Arrowhead Research reported $17.86M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Anika Therapeutics ANIK:US $ 17.5M 489K
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Bluebird Bio BLUE:US $ 68.28M 10.3M
Cerulean Pharma CERU:US $ 2.24M 413.69K
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Ligand Pharmaceuticals LGND:US $ 12.72M 1.99M
Merk MRK:US $ 2.27B 9M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Moderna Inc MRNA:US 168M 47M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Novartis NOVN:VX 3.6B 109M
Opko Health OPK:US $ 105.12M 8.12M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Spectrum Pharmaceuticals SPPI:US $ 12.24M 2.71M
Tg Therapeutics TGTX:US $ 34.9M 882K
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Xencor XNCR:US $ 10.37M 1.51M
YTE INCY:US $ 190.7M 21.84M